Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - ACCOUNTS PAYABLE
Accounts Payable INBX - Inhibrx Biosciences, Inc.
8.31 M
LAST VALUE
-4.56%
2 YEAR CAGR
4.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR